Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ASPIRA WOMEN'S HEALTH INC.

(AWH)
  Report
Delayed Nasdaq  -  04:00 2022-09-30 pm EDT
0.3722 USD   -4.56%
09/19Aspira Women's Health Inc.(NasdaqCM:AWH) dropped from S&P Global BMI Index
CI
09/12Aspira Women's Health Announces Publication of its Second-Generation MultiVariate Index Assay, OVERA®, in the Detection of Cancer in Filipino Women
AQ
09/12Aspira Women's Health Inc. Announces Publication of Its Second-Generation Multivariate Index Assay, Overa®, in the Detection of Cancer in Filipino Women
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Aspira Women's Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022

08/10/2022 | 05:23pm EDT

Aspira Women's Health Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was USD 2.07 million compared to USD 1.8 million a year ago. Net loss was USD 8.24 million compared to USD 7.07 million a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.06 a year ago. Diluted loss per share from continuing operations was USD 0.07 compared to USD 0.06 a year ago.
For the six months, revenue was USD 3.96 million compared to USD 3.3 million a year ago. Net loss was USD 17.51 million compared to USD 12.99 million a year ago. Basic loss per share from continuing operations was USD 0.16 compared to USD 0.12 a year ago. Diluted loss per share from continuing operations was USD 0.16 compared to USD 0.12 a year ago.


© S&P Capital IQ 2022
Stocks mentioned in the article
ChangeLast1st jan.
ASPIRA WOMEN'S HEALTH INC. -4.56% 0.3722 Delayed Quote.-78.97%
PAX DOLLAR (USDP/USD) -0.23% 0.9997 End-of-day quote.-0.02%
All news about ASPIRA WOMEN'S HEALTH INC.
09/19Aspira Women's Health Inc.(NasdaqCM:AWH) dropped fro..
CI
09/12Aspira Women's Health Announces Publication of its Second-Generation MultiVariate Index..
AQ
09/12Aspira Women's Health Inc. Announces Publication of Its Second-Generation Multivariate ..
CI
08/24Aspira Women's Health Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/24Transcript : Aspira Women's Health Inc. - Special Call
CI
08/23Sector Update: Health Care Stocks Declining in Late Trade
MT
08/23Sector Update: Health Care Stocks Dropping in Afternoon Trade
MT
08/23Sector Update: Health Care
MT
08/23Aspira Women's Health Prices $9 Million Public Offering of Common Shares, Warrants
MT
08/23Wall Street Stabilizes Pre-Bell After Slump Fueled by Rate Hike Concerns
MT
More news
Analyst Recommendations on ASPIRA WOMEN'S HEALTH INC.
More recommendations
Financials (USD)
Sales 2022 9,15 M - -
Net income 2022 -33,1 M - -
Net Debt 2022 - - -
P/E ratio 2022 -1,31x
Yield 2022 -
Capitalization 46,3 M 46,3 M -
Capi. / Sales 2022 5,06x
Capi. / Sales 2023 2,61x
Nbr of Employees 107
Free-Float 50,7%
Chart ASPIRA WOMEN'S HEALTH INC.
Duration : Period :
Aspira Women's Health Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASPIRA WOMEN'S HEALTH INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 0,37 $
Average target price 3,00 $
Spread / Average Target 706%
EPS Revisions
Managers and Directors
Nicole Sandford President, Chief Executive Officer & Director
Robert Beechey Chief Financial Officer
Valerie Barber Palmieri Executive Chairman
Justin DeGrazia Senior Director-Research & Development
Charles J. Dunton Chief Medical Officer
Sector and Competitors